SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (9143)1/5/2006 4:06:40 PM
From: A.J. Mullen  Read Replies (1) | Respond to of 10280
 
Thanks, if Roserem increases REM sleep then maybe it's worthwhile despite what seemed like insignificant increases in sleep duration; quality over quantity. If Lunesta and Ambien don't alter sleep architecture, then doesn't that suggests REM PROportion remains the same, and the absolute amount increases?

Ashley



To: Biomaven who wrote (9143)1/5/2006 4:23:33 PM
From: IRWIN JAMES FRANKEL  Read Replies (1) | Respond to of 10280
 
>>Melatonin increases REM sleep, so I'm guessing that Rozerem might do the same. Lunesta and Ambien basically don't alter sleep architecture, so portion of REM sleep should be pretty much unchanged.

It is hard for me to understand the reduction in depression attributed to Lunesta (used in conjunction with SSRI's) without REM sleep being induced.

Or am I just jumping to unsupportable conclusions again?

:-)

ij


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News